CL250103C96000
- 0.20
- 0.000.00%
Colgate-Palmolive Newsroom
Colgate-Palmolive Is Maintained at Buy by TD Cowen
Colgate-Palmolive Analyst Ratings
Goldman Sachs Cuts Price Target on Colgate-Palmolive to $106 From $108
TD Cowen Maintains Colgate-Palmolive(CL.US) With Buy Rating, Cuts Target Price to $100
Colgate-Palmolive Price Target Cut to $83.00/Share From $92.00 by Wells Fargo
Colgate-Palmolive Is Maintained at Underweight by Wells Fargo
Wells Fargo Maintains Colgate-Palmolive(CL.US) With Sell Rating, Cuts Target Price to $83
Wells Fargo Reaffirms Their Sell Rating on Colgate-Palmolive (CL)
Colgate-Palmolive Analyst Ratings
Piper Sandler Maintains Colgate-Palmolive(CL.US) With Buy Rating, Cuts Target Price to $112
Jefferies Maintains Colgate-Palmolive(CL.US) With Hold Rating, Cuts Target Price to $98
BNP Paribas Exane Adjusts Price Target on Colgate-Palmolive to $106 From $112, Keeps Outperform Rating
Jefferies Adjusts Colgate-Palmolive Price Target to $98 From $101, Maintains Hold Rating
Deutsche Bank Adjusts Colgate-Palmolive Price Target to $100 From $105
Deutsche Bank Maintains Colgate-Palmolive(CL.US) With Hold Rating, Cuts Target Price to $100
Morgan Stanley Sticks to Their Buy Rating for Colgate-Palmolive (CL)
DBS Maintains Colgate-Palmolive(CL.US) With Hold Rating, Announces Target Price $104
Colgate-Palmolive: Hold Rating Amid Strong Performance and Limited Upside Potential
BofA Securities Maintains Colgate-Palmolive(CL.US) With Buy Rating
Morgan Stanley Maintains Colgate-Palmolive(CL.US) With Buy Rating, Maintains Target Price $111